Skip to content
healthcare.dev
Get a free key

NYPOZI

NDC 69097-430, filgrastim-txid, injection, from Cipla USA Inc..

Product NDC
69097-430
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
INJECTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761126
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-430 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FILGRASTIM300 ug/300ug

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
69097-430-67690970430671 SYRINGE, GLASS in 1 CARTON (69097-430-67) / 300 ug in 1 SYRINGE, GLASS
69097-430-966909704309610 SYRINGE, GLASS in 1 CARTON (69097-430-96) / 300 ug in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/575d164d-45fa-4e3e-81e4-2652d96673d1

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=69097-430

Use it

Look up 69097-430 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-430 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-430. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.